𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P01-3 Discoidin domain receptor 1 is a new mediator of insulin receptor in breast cancer cells

✍ Scribed by Morcavallo, A.; Palummo, A.; Voci, C.; Sacco, A.; Albanito, L.; Malaguarnera, R.; Belfiore, A.

Book ID
121993388
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
159 KB
Volume
22
Category
Article
ISSN
1096-6374

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Insulin receptor substrate 1 is a target
Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells
✍ Michele Salerno; Diego Sisci; Loredana Mauro; Marina A. Guvakova; Sebastiano And πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 93 KB

The pure antiestrogen ICI 182,780 inhibits insulin-like growth factor (IGF)-dependent proliferation in hormoneresponsive breast cancer cells. However, the interactions of ICI 182,780 with IGF-I receptor (IGF-IR) intracellular signaling have not been characterized. Here, we studied the effects of ICI

RNAi-mediated silencing of insulin recep
RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells
✍ Gregory Cesarone; Cecilia Garofalo; Marc T. Abrams; Olga Igoucheva; Vitali Alexe πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 269 KB

## Abstract Insulin receptor substrate 1 (IRS‐1) is a major downstream signaling protein for insulin and insulin‐like growth factor I (IGF‐I) receptors, conveying signals to PI‐3K/Akt and ERK1/2 pathways. In breast cancer, IRS‐1 overexpression has been associated with tumor development, hormone‐ind